Related Experiment Videos
Evidence for virus-encoded glycosylation specificity
Summary
Mutations in the Paramecium bursaria chlorella virus (PBCV-1) alter its surface glycoproteins, changing its serological specificity. These changes are due to mutations affecting glycosylation, not the viral protein sequence.
Area of Science:
- Virology
- Molecular Biology
- Glycobiology
Background:
- Paramecium bursaria chlorella virus (PBCV-1) is a large double-stranded DNA virus.
- Viral serological specificity is typically determined by surface glycoproteins.
- Glycosylation, the process of adding glycans to proteins, is usually host-dependent.
Purpose of the Study:
- To investigate the basis of serological variation in PBCV-1 mutants.
- To identify the viral components responsible for PBCV-1 serological specificity.
- To understand the mechanism of altered glycosylation in PBCV-1 mutants.
Main Methods:
- Isolation of four spontaneously derived PBCV-1 mutants using polyclonal antiserum.
- Analysis of viral glycoproteins, specifically the major capsid protein and two minor glycoproteins.
- Comparison of viral protein sequences and glycosylation patterns among wild-type and mutant viruses.
Main Results:
- Serological specificity of PBCV-1 is determined by oligosaccharides on the major capsid protein and two minor glycoproteins.
- Mutant viruses exhibited altered glycosylation patterns compared to the wild-type.
- The amino acid sequence of the major capsid protein remained unchanged in all serotypes, ruling out mutations in glycosylation sites.
- All viruses were propagated in the same host alga, excluding host-specific alterations.
Conclusions:
- PBCV-1 serological specificity is dictated by its glycan structures.
- Mutations affecting specific glycosylation steps, potentially inactivating glycosyltransferases, explain the observed antiserum resistance.
- These findings provide insights into viral evolution and the mechanisms of viral immune evasion.